Uniform treatment thresholds for hyperbilirubinemia in preterm infants: Background and synopsis of a national guideline

BARTrial study group; Antonius Mulder

doi:10.1016/j.earlhumdev.2011.04.004

Uniform treatment thresholds for hyperbilirubinemia in preterm infants: Background and synopsis of a national guideline

BARTrial study group, Antonius Mulder

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	521-525
Journal	Early Human Development
Volume	87
Issue number	8
DOIs	https://doi.org/10.1016/j.earlhumdev.2011.04.004
Publication status	Published - Aug 2011

Keywords

Guidelines
Hyperbilirubinemia
Preterm infants
Treatment
Risk factors

Access to Document

10.1016/j.earlhumdev.2011.04.004

Cite this

@article{985c9bbb4d784f9b98d3e3c0c2e2ce89,

title = "Uniform treatment thresholds for hyperbilirubinemia in preterm infants: Background and synopsis of a national guideline",

keywords = "Guidelines, Hyperbilirubinemia, Preterm infants, Treatment, Risk factors",

author = "{van Imhoff}, {Deirdre Elisabeth} and Dijk, {Peter Hendrik} and {BARTrial study group} and Antonius Mulder and Hulzebos, {Christian Victor}",

year = "2011",

month = aug,

doi = "10.1016/j.earlhumdev.2011.04.004",

language = "English",

volume = "87",

pages = "521--525",

journal = "Early Human Development",

issn = "0378-3782",

publisher = "Elsevier Ireland Ltd",

number = "8",

}

TY - JOUR

T1 - Uniform treatment thresholds for hyperbilirubinemia in preterm infants: Background and synopsis of a national guideline

AU - van Imhoff, Deirdre Elisabeth

AU - Dijk, Peter Hendrik

AU - BARTrial study group

AU - Mulder, Antonius

AU - Hulzebos, Christian Victor

PY - 2011/8

Y1 - 2011/8

KW - Guidelines

KW - Hyperbilirubinemia

KW - Preterm infants

KW - Treatment

KW - Risk factors

U2 - 10.1016/j.earlhumdev.2011.04.004

DO - 10.1016/j.earlhumdev.2011.04.004

M3 - Article

VL - 87

SP - 521

EP - 525

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - 8

ER -